BMO Investments Inc. Announces Proposed Changes to its

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
BMO Investments Inc. Announces Proposed Changes to its Mutual Fund Lineup

TORONTO, ONTARIO--(Marketwired - July 8, 2016) - BMO Investments Inc. (BMOII) today announced changes to the BMO Mutual Funds lineup. These changes include a proposal to merge mutual funds to streamline the product suite and to implement certain fee reductions.

Proposed Fund Mergers

Subject to obtaining all necessary securityholder and regulatory approvals, BMOII proposes that each Terminating Fund listed in the table below be merged into the corresponding Continuing Fund also listed below. If approved, the mergers will be effective on or about the dates set out below:

Terminating Fund Continuing Fund Effective Date
BMO Canadian Low Volatility ETF Class BMO Global Low Volatility ETF Class September 23, 2016
BMO High Yield Bond Fund BMO U.S. High Yield Bond Fund October 14, 2016
BMO Enhanced Equity Income Fund BMO Dividend Fund September 23, 2016
BMO Canadian Diversified Monthly Income Fund BMO Diversified Income Portfolio October 14, 2016
BMO Global Monthly Income Fund BMO Global Diversified Fund September 23, 2016

Approval from securityholders of the Terminating Funds and BMO Global Low Volatility ETF Class will be sought at special meetings to be held on or about September 16, 2016 . In advance of the meetings, full details of the proposed mergers will be set out in a notice of meetings and management information circular that will be sent in late August 2016 to securityholders of record as at August 5, 2016 . The notice of meetings and management information circular will also be available on SEDAR at www.sedar.com .

If the proposed mergers are approved, securityholders of each series of each Terminating Fund will receive securities of the equivalent series of the corresponding Continuing Fund, determined on a dollar-for-dollar basis. If the proposed mergers are approved, purchases of, and switches to, securities of the Terminating Funds will be suspended after the close of business on September 20, 2016 or October 11, as applicable, depending on the effective date of each merger. The Terminating Funds will be wound up as soon as possible following the mergers. The Independent Review Committee of the funds listed above has reviewed the potential conflict of interest matters related to the proposed mergers and has provided BMOII, the manager of the funds, with a positive recommendation for each merger after determining that each merger, if implemented, achieves a fair and reasonable result for the applicable funds.

Fee Reductions

Effective July 15, 2016, BMOII will reduce the management fees on certain funds and series as outlined in the table below.

Current Annual Management Fee New Management Fee
BMO Global Low Volatility ETF Class Series A 1.45 % 1.35 %
BMO Global Low Volatility ETF Class Series F 0.60 % 0.55 %
BMO Global Low Volatility ETF Class Advisor Series 1.45 % 1.35 %
BMO Global Low Volatility ETF Class Series T6 1.45 % 1.35 %
BMO Dividend Fund Series D 0.95 % 0.90 %
BMO U.S. High Yield Bond Fund Series A 1.75 % 1.60 %
BMO U.S. High Yield Bond Fund Series F 0.55 % 0.45 %
BMO U.S. High Yield Bond Fund Advisor Series 1.75 % 1.60 %

In addition, effective July 15, 2016, BMOII will reduce the Administration Fee on BMO U.S. High Yield Bond Fund and BMO Diversified Income Portfolio from 0.28 per cent to 0.25 per cent and 0.25 per cent to 0.20 per cent, respectively.

For more information on BMO Mutual Funds, please visit www.bmo.com/gam/ca .

Get the latest BMO press releases via Twitter by following @BMOmedia.

BMO Mutual Funds are offered by BMO Investments Inc., a financial services firm and separate legal entity from Bank of Montreal.

About BMO Financial Group

Established in 1817, BMO Financial Group is a highly diversified financial services provider based in North America. With total assets of $681 billion as of April 30, 2016, and over 45,000 employees, BMO provides a broad range of retail banking, wealth management and investment banking products and services to more than 12 million customers and conducts business through three operating groups: Personal and Commercial Banking, Wealth Management and BMO Capital Markets.

Media Contacts: Mark Beazley, Toronto mark.beazley@bmo.com 416-867-3996 Valérie Doucet, Montreal valerie.doucet@bmo.com 514-877-8224
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 39

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 62

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 287

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 210

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 116

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 139

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 385

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 187

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading

Top 5 Most Recently Viewed Articles

IONQ Achieves Record Stock Levels Amid Strong Growth Indicators

Updated Category News Views 243

IONQ Stock Reaches New Heights Recently, IONQ has made headlines as its stock skyrocketed to an unprecedented level of $47.41, marking a significant achievement for the company. With a robust market capitalization of $10.2 billion, this remarkable performance is a testament to the company's impressive growth trajectory and the strong belief investors hold in its future....

Continue Reading
Model 1 Commercial Vehicles Expands Leadership Team for Growth

Updated Category News Views 285

Model 1 Commercial Vehicles Announces Leadership Changes Model 1 Commercial Vehicles is thrilled to unveil a set of key leadership appointments aimed at enhancing its strategic direction and ensuring the company's ongoing success. These changes reflect the impressive growth trajectory the company has experienced over the past few years. Tony Matijevich Takes the Helm as...

Continue Reading
Texas Instruments: Unusual Options Trends Uncovered

Updated Category News Views 195

Texas Instruments Options Insights Financial powerhouses have made a notable bullish move on Texas Instruments. Our analysis reveals intriguing trends within the options market for Texas Instruments (NASDAQ: TXN), showcasing an unusual number of trades that pinpoint shifting market sentiments. Trading Sentiment Overview Diving deeper into the data, it appears that 58% of...

Continue Reading
SMCP Unveils Latest Interim Financial Report for 2025

Updated Category News Views 177

SMCP Announces Availability of Its Interim Financial Report SMCP is excited to share that its interim financial report for the six-month period ending June 30, 2025, is now available for public access. This report has been officially filed with the relevant regulatory authorities. Details on the Financial Report This financial report outlines the company's performance...

Continue Reading
Kevin O'Leary Discusses Business Leaders' Support for Trump

Updated Category News Views 159

Understanding O'Leary's Perspective on Business Leadership Kevin O’Leary, a prominent entrepreneur and investor from Shark Tank, has provided insight into the evolving relationship between business leaders and President Trump. In recent discussions, O’Leary emphasized that the admiration many tech CEOs and corporate leaders have for Trump is not solely about his tax...

Continue Reading